Overview

Evaluating the Pharmacokinetic Characteristics of AD-102 in Healthy Volunteers

Status:
Completed
Trial end date:
2019-04-08
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetic characteristics of AD-102 in healthy male subjects
Phase:
Phase 1
Details
Lead Sponsor:
Addpharma Inc.
Treatments:
Cholecalciferol
Raloxifene Hydrochloride